Vandenbroucke JP - Search Results

1

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis.

Nurmohamed MT, Rosendaal FR, Büller HR, Dekker E, Hommes DW, Vandenbroucke JP, Briët E. Nurmohamed MT, et al. Among authors: vandenbroucke jp. Lancet. 1992 Jul 18;340(8812):152-6. doi: 10.1016/0140-6736(92)93223-a. Lancet. 1992. PMID: 1352573 Free article.

2

Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis.

Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Koster T, et al. Among authors: vandenbroucke jp. Lancet. 1995 Jan 21;345(8943):152-5. doi: 10.1016/s0140-6736(95)90166-3. Lancet. 1995. PMID: 7823669

3

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.

Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR. Vandenbroucke JP, et al. Lancet. 1994 Nov 26;344(8935):1453-7. doi: 10.1016/s0140-6736(94)90286-0. Lancet. 1994. PMID: 7968118 Free article.

4

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Koster T, et al. Among authors: vandenbroucke jp. Lancet. 1993 Dec 18-25;342(8886-8887):1503-6. doi: 10.1016/s0140-6736(05)80081-9. Lancet. 1993. PMID: 7902898

5

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.

Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Büller HR, Vandenbroucke JP. Bloemenkamp KW, et al. Among authors: vandenbroucke jp. Lancet. 1995 Dec 16;346(8990):1593-6. doi: 10.1016/s0140-6736(95)91929-5. Lancet. 1995. PMID: 7500751

6

Publication bias.

Vandenbroucke JP, Rosendaal FR. Vandenbroucke JP, et al. Lancet. 1994 Jan 8;343(8889):119. doi: 10.1016/s0140-6736(94)90848-6. Lancet. 1994. PMID: 7903754 No abstract available.

7

John Hageman's factor and deep-vein thrombosis: Leiden thrombophilia Study.

Koster T, Rosendaal FR, Briët E, Vandenbroucke JP. Koster T, et al. Among authors: vandenbroucke jp. Br J Haematol. 1994 Jun;87(2):422-4. doi: 10.1111/j.1365-2141.1994.tb04937.x. Br J Haematol. 1994. PMID: 7947293 Free article.

8

Is publication bias a medical problem?

de Melker HE, Rosendaal FR, Vandenbroucke JP. de Melker HE, et al. Among authors: vandenbroucke jp. Lancet. 1993 Sep 4;342(8871):621. doi: 10.1016/0140-6736(93)91449-v. Lancet. 1993. PMID: 8102753 No abstract available.

9

Factor V Leiden: should we screen oral contraceptive users and pregnant women?

Vandenbroucke JP, van der Meer FJ, Helmerhorst FM, Rosendaal FR. Vandenbroucke JP, et al. BMJ. 1996 Nov 2;313(7065):1127-30. doi: 10.1136/bmj.313.7065.1127. BMJ. 1996. PMID: 8916702 Free PMC article. Review.

10

End of the line for "third-generation-pill" controversy?

Vandenbroucke JP, Rosendaal FR. Vandenbroucke JP, et al. Lancet. 1997 Apr 19;349(9059):1113-4. doi: 10.1016/S0140-6736(05)63015-2. Lancet. 1997. PMID: 9113005

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

626 results

Search Page

Filters